New CRC publication:  Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency   Promising results on a phase 2 clinical study entitled "Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency" was recently published in The New England Journal of Medicine. Alpha1-antitrypsin deficiency is an inherited, proteotoxic disorder [...]